Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.

Saved in:

Bibliographic Details
Title:	Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.
Authors:	Woodman N; Breast Research Pathology, King's College London, Guy's Hospital, London, UK., Pinder SE; Breast Research Pathology, King's College London, Guy's Hospital, London, UK., Tajadura V; Breast Cancer Biology, Research Oncology, King's College London, Guy's Hospital, London, UK., Le Bourhis X; University of Lille, INSERM, U908 - CPAC, Cell Plasticity and Cancer, Lille, Villeneuve d'Ascq, France., Gillett C; Breast Research Pathology, King's College London, Guy's Hospital, London, UK., Delannoy P; University of Lille, CNRS, UMR 8576 - UGSF, Unit of Structural and Functional Glycobiology, Lille, Villeneuve d'Ascq, France., Burchell JM; Breast Cancer Biology, Research Oncology, King's College London, Guy's Hospital, London, UK., Julien S; University of Lille, INSERM, U908 - CPAC, Cell Plasticity and Cancer, Lille, Villeneuve d'Ascq, France.
Source:	International journal of oncology [Int J Oncol] 2016 Jul; Vol. 49 (1), pp. 265-75. Date of Electronic Publication: 2016 May 13.
Publication Type:	Journal Article
Journal Info:	Publisher: D.A. Spandidos Country of Publication: Greece NLM ID: 9306042 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1791-2423 (Electronic) Linking ISSN: 10196439 NLM ISO Abbreviation: Int J Oncol Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1791-2423
DOI:	10.3892/ijo.2016.3521